tiprankstipranks
Trending News
More News >

Scott A. Gangloff Insider Profile

4 Followers
Scott A. Gangloff, SVP, Development & Mfrg at Oncobiologics Inc, holds 0.00 shares in Akero Therapeutics (Ticker: AKRO), holds 78.57K shares in Oncobiologics Inc (Ticker: ONSIU), holds 78.57K shares in Outlook Therapeutics (Ticker: OTLK).
tipranks
Scott A. Gangloff

Scott A. Gangloff
Oncobiologics Inc (ONSIU)
SVP, Development & Mfrg

Ranked #37,825 out of 105,077 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+32.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$156K
100.00%
0.00%
A breakdown of Scott A. Gangloff's holdings

Insider Roles

Outlook Therapeutics
(OTLK)
SVP, Development & Mfrg
Akero Therapeutics
(AKRO)
CTO
Roles that Scott A. Gangloff holds in companies

Most Profitable Insider Trade

Stock:
Outlook Therapeutics
(OTLK)
Rating:Informative Sell
Date:Nov 14, 2016 - Nov 14, 2017
Return:+65.90%
The most profitable trade made by Scott A. Gangloff

Scott A. Gangloff's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ONSIU
Oncobiologics Inc
Dec 22, 2016
Uninformative Buy
$370.86K
Akero Therapeutics
Dec 09, 2025
CTO
Uninformative Sell
$0.00
Outlook Therapeutics
Nov 14, 2016
SVP, Development & Mfrg
Uninformative Buy
318.22K
$155.57K
List of latest transactions for each holding click on a transaction to see Scott A. Gangloff's performance on stock

Scott A. Gangloff insider profile FAQ

What is the percentage of profitable transactions made by Scott A. Gangloff?
The percentage of profitable transactions made by Scott A. Gangloff is 50%.
    What is the average return per transaction made by Scott A. Gangloff?
    The average return per transaction made by Scott A. Gangloff is 32.60%.
      What stocks does Scott A. Gangloff hold?
      Scott A. Gangloff holds: ONSIU, AKRO, OTLK stocks.
        What was Scott A. Gangloff’s latest transaction?
        Scott A. Gangloff latest transaction was an Uninformative Sell of ―.
          What was Scott A. Gangloff's most profitable transaction?
          Scott A. Gangloff’s most profitable transaction was an Informative Sell of OTLK stock on November 14, 2016. The return on the trade was 65.90%.
            What is Scott A. Gangloff's role in Oncobiologics Inc?
            Scott A. Gangloff's role in Oncobiologics Inc is SVP, Development & Mfrg.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.